PROCESS OF PREPARATION OF FORMULATIONS OF THE PEPTIDE ANGIOTENSIN-(1-7) AND ITS ANALOGUES, AGONISTIC AND ANTAGONISTS USING CYCLODEXTRINS, LIPOSSOMES AND BIODEGRADABLE POLYMERS AND/OR MIXTURES AND PRODUCTS THEREOF

摘要

There is no description in the state of technique of a formulation, application or product of D-Ala<7>-Angiotensin-(1-7) (A-779) and analogues and derivatives, D-Pro<7>-Angiotensin-(1-7) and analogues or derivatives or of Ang-(1-7) analogues or derivatives using ciclodextrines, lipossomes, biodegradable polymers and its derivatives for the study or treatment of arterial hypertension and other cardiovascular diseases and its complications, wounds, burns, erithema, tumors, diabetes mellitus, sperm mobility, nephropathy, gastrointestinal and gynaecological disorders, angiogenesis, angioplatsy, alopecia and blood diseases in animals of warm blood, or as ligands for de G-protein-coupled receptor MAS. This characterizes the present invention as a more effective option for the study and treatment of pathologies associated or not to this receptor. The present invention is characterized by the combination of two different technologies: the molecular encapsulament of the peptide angiotensin-(1-7) and its analogues and derivates in cyclodextrin and the microencapsulament in biodegradable polymers and lipossomes. It is also characterized by the increase of this peptides and its analogues and derivatives using the formulation of the present invention.